{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T02:45:51Z","timestamp":1788749151227,"version":"build-2803163510"},"reference-count":10,"publisher":"Hindawi Limited","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2001,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1111\/j.1365-2710.2009.01099.x","type":"journal-article","created":{"date-parts":[[2010,3,10]],"date-time":"2010-03-10T08:06:38Z","timestamp":1268208398000},"page":"289-301","source":"Crossref","is-referenced-by-count":56,"title":["Approval of new drugs 1999-2007: comparison of the US, the EU and Japan situations"],"prefix":"10.1155","volume":"35","author":[{"given":"K.","family":"Tsuji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Tsutani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"98","published-online":{"date-parts":[[2010,3,10]]},"reference":[{"key":"10.1111\/j.1365-2710.2009.01099.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"14773","DOI":"10.1002\/cpt1973145773","article-title":"Introduction of new therapeutic drugs in the United States and Great Britain: an international comparison","volume":"14","author":"Wardell","year":"1973","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1111\/j.1365-2710.2009.01099.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/cpt1978245499","article-title":"The drug lag revisited: comparison by therapeutic area of patterns of drugs marketed in the United States and Great Britain from 1972 through 1976","volume":"24","author":"Wardell","year":"1978","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1111\/j.1365-2710.2009.01099.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2190\/9Y32-X86Y-M3F0-JQFC","article-title":"The drug lag issue: the debate seen from an international perspective","volume":"22","author":"Anderson","year":"1992","journal-title":"International Journal of Health Services"},{"key":"10.1111\/j.1365-2710.2009.01099.x-BIB4|cit4","first-page":"138","article-title":"Who has a drug lag?","volume":"6","author":"Parker","year":"1989","journal-title":"Journal of Social Administrative Pharmacy"},{"key":"10.1111\/j.1365-2710.2009.01099.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/mde.4090100407","article-title":"Who has a drug lag?","volume":"10","author":"Parker","year":"1989","journal-title":"Managerial and Decision Economics"},{"key":"10.1111\/j.1365-2710.2009.01099.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/clpt.1989.116","article-title":"The drug lag: an update of new drug introductions in the United States and in the United Kingdom, 1977 through 1987","volume":"46","author":"Keitin","year":"1989","journal-title":"Clinical Pharmacololy and Therapeutics"},{"key":"10.1111\/j.1365-2710.2009.01099.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ejpb.2007.07.013","article-title":"Approval of biopharmaceuticals 1999-2006: comparison of the US, EU and Japan situation","volume":"68","author":"Tsuji","year":"2008","journal-title":"European Journal of Pharmaceutics and Biopharmaceutics"},{"key":"10.1111\/j.1365-2710.2009.01099.x-BIB8|cit8","unstructured":"IMS Health IMS Lifecycle http:\/\/www.imshealth.com\/web\/product\/0,3155,64576068_63872702_71263548_71461362,00.html"},{"key":"10.1111\/j.1365-2710.2009.01099.x-BIB9|cit9","volume-title":"Iyakushin No. 1015. HIV Kansenshou Chiryouyaku no Seizo mataha Yunyuu no Toriatsukai nit tuite (Notification on handling of manufacturing or import of antivirals)","author":"MHLW","year":"1998"},{"key":"10.1111\/j.1365-2710.2009.01099.x-BIB10|cit10","unstructured":"MHLW Mishounin-yaku Shiyou-mondai Kentoukaigi (the Committee for the use of unapproved drugs) http:\/\/www.mhlw.go.jp\/shingi\/2005\/01\/s0124-9.html"}],"container-title":["Journal of Clinical Pharmacy and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2710.2009.01099.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2710.2009.01099.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T18:03:22Z","timestamp":1671818602000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2710.2009.01099.x"}},"subtitle":["Approval of new drugs in the US, the EU and Japan 1999-2007"],"short-title":[],"issued":{"date-parts":[[2010,3,10]]},"references-count":10,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2710.2009.01099.x","relation":{},"ISSN":["0269-4727","1365-2710"],"issn-type":[{"value":"0269-4727","type":"print"},{"value":"1365-2710","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3,10]]}}}